New York City's EB-1A ecosystem

Why NYC generates so many EB-1A petitions.

New York City produces EB-1A petitions at a rate second only to the San Francisco Bay Area, driven by the same two talent pools that generate O-1A filings in volume. Academic researchers at Columbia, NYU, Rockefeller, MSK, Weill Cornell, and Mount Sinai self-petition for extraordinary ability green cards as a parallel path to employer-sponsored EB-1B. Finance professionals — portfolio managers, quantitative analysts, and fintech founders — self-petition EB-1A on the strength of published financial research, press coverage, and compensation records that require no employer involvement at all.

The advantage of EB-1A self-petition is portability: the approved I-140 does not depend on continued employment with any particular institution. For a researcher at Rockefeller who may eventually move to Columbia or a private biotech, and for a portfolio manager who may change firms, the green card remains intact. USCIS Nebraska Service Center handles NYC I-140 petitions and has developed well-established adjudication patterns for both academic and finance profiles over many years of volume filing from New York's institutions and firms.

The priority date calculus also drives timing. For Indian-born researchers and finance professionals, the EB-1 backlog — though shorter than the EB-2 India queue — is not always current. Filing the EB-1A self-petition as soon as the record is ready, even before an employer-sponsored EB-1B is filed, can establish an earlier priority date that accelerates the final step to permanent residence by a year or more.

Key institutions

Where New York EB-1A petitions originate.

These institutions and employers generate the largest share of NYC EB-1A petitions. Notes are tailored to EB-1A self-petition strategy at each.

Columbia University & CUIMC
Top-5 NIH-funded private medical school; institutional EB-1B sponsorship available for permanent faculty, but researchers frequently self-petition EB-1A independently to establish an earlier priority date or as a parallel track to Columbia's own filing.
NYU & NYU Langone Medical Center
Comprehensive university with Courant Institute (math/CS/AI) and Langone for clinical research; institutional immigration office handles EB-1B, but self-petitioned EB-1A through outside counsel is common for researchers who want a parallel track or faster priority date.
Rockefeller University
Research-only institution; all faculty are active PIs with high publication and citation density; Rockefeller sponsors EB-1B, and most researchers simultaneously self-petition EB-1A; decades of successful Nebraska Service Center adjudication history for Rockefeller profiles.
Memorial Sloan Kettering Cancer Center
Dedicated immigration office processes EB-1B for clinical and basic scientists; MSK researchers commonly self-petition EB-1A concurrently through outside counsel; strong oncology and translational research publication records support both filings simultaneously.
Weill Cornell Medicine & Mount Sinai
Upper East Side medical corridor; both sponsor EB-1B for permanent faculty and research scientists; researchers at Icahn School (top-20 NIH-funded) and Weill Cornell with strong genomics, immunology, or cardiovascular research records commonly pursue parallel EB-1A self-petition.
Wall Street, Hedge Funds & NYC Fintech
Two Sigma, Renaissance Technologies, Citadel NYC, and boutique funds; fintech companies; senior finance professionals self-petition EB-1A without employer involvement; finance compensation surveys (Glocap, Options Group) and WSJ/Bloomberg press coverage form the core evidentiary package.
Eligibility

EB-1A criteria for New York profiles.

EB-1A requires at least three of ten regulatory criteria, plus a finding of sustained national or international acclaim. For NYC researchers and finance professionals, these five are most frequently relied upon:

01

Published material about the beneficiary and their work

Academic: Nature, Science, Cell, NEJM, JAMA, and subspecialty journals; invited review articles; media coverage in The Scientist and Science News. Finance: Bloomberg, WSJ, Financial Times, Institutional Investor, Barron's; CFA Institute publications; profiles in financial press. Biotech: STAT News, BioPharma Dive, Endpoints News. The 2025 USCIS policy update explicitly extended this to digital and online sources, strengthening finance and biotech profiles.

02

Original contributions of major significance

Academic: NIH- and NSF-funded discoveries with citation evidence; field-altering findings cited by subsequent studies. Finance: novel trading strategies or financial models documented through adoption by other institutions; patents on financial instruments or risk systems; published research from which the broader financial community has drawn. For both profiles, demonstrating that others have built on the work — not just that it exists — is the critical showing.

03

Critical or leading role in a distinguished organization

PI at Columbia, NYU, Rockefeller, or MSK; Chief Investment Officer or Portfolio Manager at a named hedge fund with documented AUM; founding team or C-suite at a named NYC fintech or biotech; laboratory director at a major academic medical center. Self-petition means the organization's distinction is documented through independent evidence — an employer letter is not required, but institutional prestige and the petitioner's position within it must be demonstrated.

04

Judging the work of others

Academic: peer review for Nature, Science, Cell, NEJM; NIH and NSF grant study section service. Finance: CFA Institute panel membership, selection committee at NYSSA, editorial board at Journal of Finance or Review of Financial Studies, invited judging at finance competitions. Most NYC researchers and senior finance professionals are conducting far more judging activity than they document in a petition.

05

High salary or remuneration relative to peers

NYC hedge fund and senior finance compensation — including base salary, annual bonus, and carried interest — routinely places candidates in the top 5–10% nationally. Senior medical faculty at CUIMC, MSK, and Mount Sinai earn similarly above national medians in their respective fields. Documented through BLS OES or finance-specific surveys (Glocap, Options Group, Johnson Associates) accepted by USCIS Nebraska Service Center.

New York EB-1A profiles

What qualifying records look like here.

Representative profiles from New York EB-1A self-petitions. Identifying details have been generalized.

Computational Biologist
Memorial Sloan Kettering (Computational Oncology)

Single-cell RNA-seq and tumor microenvironment characterization

28 publications; h-index of 19
First-author papers in Nature Methods and Nature Cancer
NIH R01 (PI); area chair at RECOMB 2024
Reviewer for Cell Systems, PLOS Computational Biology, and Genome Biology
MSK sponsored EB-1B concurrently; petitioner self-petitioned EB-1A independently. Both I-140s filed the same week. EB-1A approved first, enabling I-485 without waiting for EB-1B.
Chief Investment Officer
Family office / single-manager fund (Manhattan)

Global macro and fixed income arbitrage

9 published research papers in financial economics journals
Institutional Investor "Rising Star" recognition; WSJ and Bloomberg profiles
AUM $800M; Milken Institute Global Conference panelist 2022 and 2024
Total compensation top 3% nationally per Options Group survey
Self-petitioned through outside counsel — no employer involvement. I-140 approved; concurrent I-485 filed given EB-1 current priority date.
Professor
Rockefeller University (Laboratory of Molecular Genetics)

mRNA biology and translational regulation in development

47 publications; h-index of 31; Howard Hughes Medical Institute Investigator
First-author papers in Nature, Cell, and Molecular Cell
Reviewer for Nature, Cell, and eLife
Invited plenary at ASCB and RNA Society Annual Meeting
Rockefeller self-petitioned EB-1B; professor independently self-petitioned EB-1A as a parallel path. EB-1A approved first; priority date immediately current.
After EB-1A approval

Filing for permanent residence from New York.

After I-140 approval, the path to a green card depends on priority date availability and whether the petitioner is already in the United States. Adjustment of status (Form I-485) is filed in the US without leaving; consular processing applies if the petitioner is abroad or prefers to attend an immigrant visa interview at a US consulate. For most nationalities in EB-1, priority dates are current or near-current, making I-485 filing possible shortly after I-140 approval.

Indian-born petitioners should monitor the monthly Visa Bulletin carefully. The EB-1 India queue is shorter than EB-2 India but still involves wait times — filing EB-1A self-petition as early as the record allows is the most effective strategy for minimizing that wait. For researchers considering both EB-1A and NIW, filing EB-1A self-petition now establishes an EB-1 priority date that will be earlier than any NIW filed later, which can matter if the EB-1A is approved but the petitioner's record eventually qualifies for both paths.

FAQ

New York EB-1A questions.

Yes. EB-1A is a self-petition — the I-140 is filed by or on behalf of the beneficiary, with no employer signature or PERM required. A portfolio manager, quant researcher, or fintech founder can file based entirely on their personal record of extraordinary ability in finance. The employer does not need to participate. For senior finance professionals at named firms, self-petition EB-1A is attractive because the green card travels with the petitioner — changing firms after I-140 approval (but before I-485) does not jeopardize the petition if the new position is in the same or a similar occupation.
The standard is the same — sustained national or international acclaim — but the evidentiary sources differ. Academic researchers rely primarily on peer-reviewed publications, citation counts, peer review activity, and grants. Finance professionals rely on published research in financial economics journals, press coverage in Bloomberg and WSJ, recognized performance records (AUM, Sharpe ratio relative to benchmark), invited leadership at CFA Institute or similar bodies, and compensation benchmarked against national peers. USCIS applies the same criteria but accepts different types of evidence for each occupation group.
For most nationalities, EB-1 priority dates are current or near-current. Indian nationals face an EB-1 backlog — shorter than the EB-2 India backlog, but not always current; monitor the monthly Visa Bulletin. For Indian-born researchers and finance professionals at NYC institutions, locking in the earliest possible I-140 filing date is critical. Filing EB-1A self-petition as soon as the record is ready — even before the employer's sponsored EB-1B is filed — can mean a year or more difference in priority date.
EB-1A I-140 approval does not depend on continued employment with the petitioner. Unlike PERM-based EB-2 or EB-3 petitions, which are employer-specific, an approved EB-1A I-140 is portable. If you file I-485 and then change employers after 180 days of pending I-485, AC21 portability applies — the new position must be in the same or a similar occupational classification. For finance professionals, this typically means staying within financial analysis, portfolio management, or closely related roles.
Yes, and this is common at NYC research institutions. The employer-sponsored EB-1B and the self-petitioned EB-1A are filed independently — the institution files the EB-1B I-140 and you (or outside counsel) file the EB-1A I-140. Two priority dates are established simultaneously. If the EB-1A is approved first and the date is current, you can proceed to I-485 without waiting for the EB-1B. Running both tracks in parallel is standard practice at MSK, Columbia, and Rockefeller.